Dr.ย Heย Huang
M.D., Ph.D.
Professor & President, First Affiliated Hospital, Zhejiang University School of Medicine
corporate_fareFirst Affiliated Hospital, Zhejiang University, Hangzhou
He Huang
M.D., Ph.D.
Prof. He Huang is one of China's foremost specialists in haematology, bone marrow transplantation, and cellular immunotherapy. He is based at the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, where he serves as President of the hospital and Director of both the Bone Marrow Transplantation Centre and the Institute of Haematology, Zhejiang University.
Prof. Huang has been engaged in haematology, hematopoietic stem cell transplantation, and cellular immunotherapy research since 1984, representing over four decades of clinical and academic work in the field. His team is recognized for creating an integrated treatment system combining CAR T-cell therapy with allogeneic hematopoietic stem cell transplantation, tailored for Chinese patient populations with malignant blood disorders. His clinical expertise spans leukaemia, lymphoma, multiple myeloma, myelodysplastic syndrome, and aplastic anaemia, including complex relapsed and refractory cases. Prof. Huang has led major national research programmes and has published extensively in journals including The New England Journal of Medicine, Nature Medicine, Blood, and Lancet Haematology. He holds multiple provincial and national science and technology awards and is recognised internationally through his roles in the European Society for Blood and Marrow Transplantation and the Asia-Pacific Blood and Marrow Transplantation Group.
CancerFax can coordinate medical report review, second opinion support, and consultation pathways for international patients seeking an evaluation from Prof. Huang's team at Zhejiang University.
Why Consider Prof. He Huang?
Prof. He Huang brings over four decades of focused expertise in blood cancer treatment, stem cell transplantation, and CAR T-cell therapy from one of China's leading academic medical centres.
Areas of Specialisation
Advanced haematology, cellular immunotherapy, and stem cell transplantation for blood cancers
Prof. He Huang's clinical and research focus centres on the most complex and advanced blood cancers, with particular expertise in CAR T-cell therapy, hematopoietic stem cell transplantation, and precision haematology.
CAR T-Cell Therapy & Cellular Immunotherapy
Advanced cellular therapy approaches for relapsed and refractory haematological malignancies.
- arrow_rightCAR-T treatment for relapsed/refractory acute lymphoblastic leukaemia
- arrow_rightCAR-T approaches for lymphoma and multiple myeloma
- arrow_rightIntegrated CAR-T plus hematopoietic stem cell transplantation strategies
- arrow_rightParticipation in formulation of CAR-T clinical treatment guidelines
- arrow_rightCellular therapy for malignant haematological diseases
- arrow_rightTranslational research in stem cell and cellular immune therapy
Hematopoietic Stem Cell Transplantation
Comprehensive bone marrow and stem cell transplant services for a range of blood disorders.
- arrow_rightAllogeneic hematopoietic stem cell transplantation adapted to Chinese patient populations
- arrow_rightTransplant strategies for leukaemia, lymphoma, and myelodysplastic syndrome
- arrow_rightBone marrow transplantation for aplastic anaemia and other complex blood disorders
- arrow_rightMolecular biology-guided transplant decision-making
- arrow_rightIntegrated pre- and post-transplant management
Haematological Malignancies
Diagnosis and treatment of a full spectrum of blood cancers and complex blood disorders.
- arrow_rightAcute and chronic leukaemia
- arrow_rightLymphoma (Hodgkin and non-Hodgkin)
- arrow_rightMultiple myeloma
- arrow_rightMyelodysplastic syndrome
- arrow_rightAplastic anaemia
Procedures Performed
Stem cell transplantation, cellular therapy, and precision haematology services
Prof. Huang's clinical team at the Bone Marrow Transplantation Centre provides comprehensive transplant and cellular therapy services for blood cancers and complex haematological disorders.
CAR T-Cell Therapy
Medical OncologyAdvanced cellular immunotherapy for relapsed and refractory blood cancers, including integrated CAR-T and transplant strategies.
Hematopoietic Stem Cell Transplantation
TransplantAllogeneic and bone marrow transplantation for leukaemia, lymphoma, myelodysplastic syndrome, and aplastic anaemia.
Complex Haematological Disease Management
Complex DiseaseMultidisciplinary management of complex, relapsed, and refractory haematological malignancies.
Second Opinion Consultations
Second OpinionExpert independent review of haematological diagnoses and treatment plans, particularly for complex or relapsed cases.
Research & Publications
Leading contributions in CAR T-cell therapy, stem cell transplantation, and precision haematology
Prof. Huang has led major national research projects including 973, 863, and National Natural Science Foundation of China key projects, and has published in top-tier medical and haematology journals.
Prof. Huang's centre is an active site for translational research in CAR T-cell therapy and stem cell transplantation. Patients with relapsed or refractory blood cancers may benefit from consultation with his team.
Education & Training
Prof. Huang completed his medical training in China and undertook advanced visiting scholar training in haematopathology in Germany, before progressing through clinical and academic roles at Zhejiang University School of Medicine.
Clinical Experience
Prof. Huang has built his entire career at the First Affiliated Hospital, Zhejiang University School of Medicine, progressing from physician to Professor, Director of the Bone Marrow Transplantation Centre, and ultimately President of the hospital.
Languages & International
Prof. Huang consults in the following language. CancerFax can arrange professional medical interpreter support for international patients.
CancerFax coordinates professional medical interpreter services for international patients requiring English or other language support during consultation.
CancerFax can coordinate professional medical interpreter support for patients consulting in English or other languages.
How CancerFax Helps You Access Dr. He Huang
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. He Huang's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. He Huang's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. He Huang before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. He Huang's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. He Huang's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. He Huang's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. He Huang
Prof. He Huang specialises in haematology, bone marrow transplantation, hematopoietic stem cell transplantation, CAR T-cell therapy, and cellular immunotherapy. His clinical expertise covers leukaemia (including acute lymphoblastic leukaemia), lymphoma, multiple myeloma, myelodysplastic syndrome, and aplastic anaemia.
Prof. He Huang is based at the First Affiliated Hospital, Zhejiang University School of Medicine, in Hangzhou, China. He serves as President of the hospital and Director of the Bone Marrow Transplantation Centre.
CancerFax can coordinate medical report review and consultation support for international patients seeking an opinion from Prof. Huang's team at Zhejiang University, subject to hospital availability and case acceptance. Please submit your reports through CancerFax to begin the process.
Submit your medical records and reports through CancerFax using the Send Your Reports option. The CancerFax team will review your case, prepare the documentation, and coordinate the next steps with the hospital, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, bone marrow biopsy results, imaging, treatment history, and relevant test results. Prof. Huang's team specialises in complex and relapsed haematological malignancies. The consultation format and availability are subject to the hospital's confirmation.
Yes. CAR T-cell therapy is a central area of Prof. Huang's clinical and research work. His team at Zhejiang University developed an integrated treatment system combining CAR-T therapy with hematopoietic stem cell transplantation for relapsed and refractory leukaemia, lymphoma, and multiple myeloma. He has also contributed to the formulation of CAR-T treatment guidelines in China.
Connect with He Huang Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.